According to our latest study, the global Cell Therapy Manufacturing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cell Therapy Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell Therapy Manufacturing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell Therapy Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell Therapy Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell Therapy Manufacturing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Therapy Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Therapy Manufacturing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Avantor, Cell Therapies, Thermo Fisher Scientific and Charles River Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell Therapy Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Autologous
Allogenic
Market segment by Application
HIV
Autoimmune Disorders
Immune Deficiencies
Cancer
Neurological Disorders
Market segment by players, this report covers
Merck KGaA
Avantor
Cell Therapies
Thermo Fisher Scientific
Charles River Laboratories
Catalent
Bio-Techne
Cytiva
Lonza
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Novartis AG
Bristol-Myers Squibb
Gilead Sciences
WuXi AppTec
OXGENE
Pharmaron
Aldevron
FLODESIGN SONICS
Exothera
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell Therapy Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Therapy Manufacturing, with revenue, gross margin and global market share of Cell Therapy Manufacturing from 2018 to 2023.
Chapter 3, the Cell Therapy Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell Therapy Manufacturing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Therapy Manufacturing.
Chapter 13, to describe Cell Therapy Manufacturing research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Cell Therapy Manufacturing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell Therapy Manufacturing by Type
1.3.1 Overview: Global Cell Therapy Manufacturing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cell Therapy Manufacturing Consumption Value Market Share by Type in 2022
1.3.3 Autologous
1.3.4 Allogenic
1.4 Global Cell Therapy Manufacturing Market by Application
1.4.1 Overview: Global Cell Therapy Manufacturing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 HIV
1.4.3 Autoimmune Disorders
1.4.4 Immune Deficiencies
1.4.5 Cancer
1.4.6 Neurological Disorders
1.5 Global Cell Therapy Manufacturing Market Size & Forecast
1.6 Global Cell Therapy Manufacturing Market Size and Forecast by Region
1.6.1 Global Cell Therapy Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cell Therapy Manufacturing Market Size by Region, (2018-2029)
1.6.3 North America Cell Therapy Manufacturing Market Size and Prospect (2018-2029)
1.6.4 Europe Cell Therapy Manufacturing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cell Therapy Manufacturing Market Size and Prospect (2018-2029)
1.6.6 South America Cell Therapy Manufacturing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cell Therapy Manufacturing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business
2.1.3 Merck KGaA Cell Therapy Manufacturing Product and Solutions
2.1.4 Merck KGaA Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck KGaA Recent Developments and Future Plans
2.2 Avantor
2.2.1 Avantor Details
2.2.2 Avantor Major Business
2.2.3 Avantor Cell Therapy Manufacturing Product and Solutions
2.2.4 Avantor Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Avantor Recent Developments and Future Plans
2.3 Cell Therapies
2.3.1 Cell Therapies Details
2.3.2 Cell Therapies Major Business
2.3.3 Cell Therapies Cell Therapy Manufacturing Product and Solutions
2.3.4 Cell Therapies Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cell Therapies Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Cell Therapy Manufacturing Product and Solutions
2.4.4 Thermo Fisher Scientific Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Charles River Laboratories
2.5.1 Charles River Laboratories Details
2.5.2 Charles River Laboratories Major Business
2.5.3 Charles River Laboratories Cell Therapy Manufacturing Product and Solutions
2.5.4 Charles River Laboratories Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Charles River Laboratories Recent Developments and Future Plans
2.6 Catalent
2.6.1 Catalent Details
2.6.2 Catalent Major Business
2.6.3 Catalent Cell Therapy Manufacturing Product and Solutions
2.6.4 Catalent Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Catalent Recent Developments and Future Plans
2.7 Bio-Techne
2.7.1 Bio-Techne Details
2.7.2 Bio-Techne Major Business
2.7.3 Bio-Techne Cell Therapy Manufacturing Product and Solutions
2.7.4 Bio-Techne Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio-Techne Recent Developments and Future Plans
2.8 Cytiva
2.8.1 Cytiva Details
2.8.2 Cytiva Major Business
2.8.3 Cytiva Cell Therapy Manufacturing Product and Solutions
2.8.4 Cytiva Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cytiva Recent Developments and Future Plans
2.9 Lonza
2.9.1 Lonza Details
2.9.2 Lonza Major Business
2.9.3 Lonza Cell Therapy Manufacturing Product and Solutions
2.9.4 Lonza Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lonza Recent Developments and Future Plans
2.10 The Discovery Labs
2.10.1 The Discovery Labs Details
2.10.2 The Discovery Labs Major Business
2.10.3 The Discovery Labs Cell Therapy Manufacturing Product and Solutions
2.10.4 The Discovery Labs Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 The Discovery Labs Recent Developments and Future Plans
2.11 BIOCENTRIQ
2.11.1 BIOCENTRIQ Details
2.11.2 BIOCENTRIQ Major Business
2.11.3 BIOCENTRIQ Cell Therapy Manufacturing Product and Solutions
2.11.4 BIOCENTRIQ Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BIOCENTRIQ Recent Developments and Future Plans
2.12 FUJIFILM Diosynth Biotechnologies
2.12.1 FUJIFILM Diosynth Biotechnologies Details
2.12.2 FUJIFILM Diosynth Biotechnologies Major Business
2.12.3 FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Product and Solutions
2.12.4 FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.13 Novartis AG
2.13.1 Novartis AG Details
2.13.2 Novartis AG Major Business
2.13.3 Novartis AG Cell Therapy Manufacturing Product and Solutions
2.13.4 Novartis AG Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Novartis AG Recent Developments and Future Plans
2.14 Bristol-Myers Squibb
2.14.1 Bristol-Myers Squibb Details
2.14.2 Bristol-Myers Squibb Major Business
2.14.3 Bristol-Myers Squibb Cell Therapy Manufacturing Product and Solutions
2.14.4 Bristol-Myers Squibb Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.15 Gilead Sciences
2.15.1 Gilead Sciences Details
2.15.2 Gilead Sciences Major Business
2.15.3 Gilead Sciences Cell Therapy Manufacturing Product and Solutions
2.15.4 Gilead Sciences Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Gilead Sciences Recent Developments and Future Plans
2.16 WuXi AppTec
2.16.1 WuXi AppTec Details
2.16.2 WuXi AppTec Major Business
2.16.3 WuXi AppTec Cell Therapy Manufacturing Product and Solutions
2.16.4 WuXi AppTec Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 WuXi AppTec Recent Developments and Future Plans
2.17 OXGENE
2.17.1 OXGENE Details
2.17.2 OXGENE Major Business
2.17.3 OXGENE Cell Therapy Manufacturing Product and Solutions
2.17.4 OXGENE Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 OXGENE Recent Developments and Future Plans
2.18 Pharmaron
2.18.1 Pharmaron Details
2.18.2 Pharmaron Major Business
2.18.3 Pharmaron Cell Therapy Manufacturing Product and Solutions
2.18.4 Pharmaron Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Pharmaron Recent Developments and Future Plans
2.19 Aldevron
2.19.1 Aldevron Details
2.19.2 Aldevron Major Business
2.19.3 Aldevron Cell Therapy Manufacturing Product and Solutions
2.19.4 Aldevron Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Aldevron Recent Developments and Future Plans
2.20 FLODESIGN SONICS
2.20.1 FLODESIGN SONICS Details
2.20.2 FLODESIGN SONICS Major Business
2.20.3 FLODESIGN SONICS Cell Therapy Manufacturing Product and Solutions
2.20.4 FLODESIGN SONICS Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 FLODESIGN SONICS Recent Developments and Future Plans
2.21 Exothera
2.21.1 Exothera Details
2.21.2 Exothera Major Business
2.21.3 Exothera Cell Therapy Manufacturing Product and Solutions
2.21.4 Exothera Cell Therapy Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Exothera Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cell Therapy Manufacturing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cell Therapy Manufacturing by Company Revenue
3.2.2 Top 3 Cell Therapy Manufacturing Players Market Share in 2022
3.2.3 Top 6 Cell Therapy Manufacturing Players Market Share in 2022
3.3 Cell Therapy Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Cell Therapy Manufacturing Market: Region Footprint
3.3.2 Cell Therapy Manufacturing Market: Company Product Type Footprint
3.3.3 Cell Therapy Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Cell Therapy Manufacturing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cell Therapy Manufacturing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Cell Therapy Manufacturing Consumption Value Market Share by Application (2018-2023)
5.2 Global Cell Therapy Manufacturing Market Forecast by Application (2024-2029)
6 North America
6.1 North America Cell Therapy Manufacturing Consumption Value by Type (2018-2029)
6.2 North America Cell Therapy Manufacturing Consumption Value by Application (2018-2029)
6.3 North America Cell Therapy Manufacturing Market Size by Country
6.3.1 North America Cell Therapy Manufacturing Consumption Value by Country (2018-2029)
6.3.2 United States Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
6.3.3 Canada Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
6.3.4 Mexico Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Cell Therapy Manufacturing Consumption Value by Type (2018-2029)
7.2 Europe Cell Therapy Manufacturing Consumption Value by Application (2018-2029)
7.3 Europe Cell Therapy Manufacturing Market Size by Country
7.3.1 Europe Cell Therapy Manufacturing Consumption Value by Country (2018-2029)
7.3.2 Germany Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
7.3.3 France Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
7.3.5 Russia Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
7.3.6 Italy Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Manufacturing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cell Therapy Manufacturing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cell Therapy Manufacturing Market Size by Region
8.3.1 Asia-Pacific Cell Therapy Manufacturing Consumption Value by Region (2018-2029)
8.3.2 China Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
8.3.3 Japan Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
8.3.4 South Korea Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
8.3.5 India Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
8.3.7 Australia Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
9 South America
9.1 South America Cell Therapy Manufacturing Consumption Value by Type (2018-2029)
9.2 South America Cell Therapy Manufacturing Consumption Value by Application (2018-2029)
9.3 South America Cell Therapy Manufacturing Market Size by Country
9.3.1 South America Cell Therapy Manufacturing Consumption Value by Country (2018-2029)
9.3.2 Brazil Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
9.3.3 Argentina Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy Manufacturing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cell Therapy Manufacturing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cell Therapy Manufacturing Market Size by Country
10.3.1 Middle East & Africa Cell Therapy Manufacturing Consumption Value by Country (2018-2029)
10.3.2 Turkey Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
10.3.4 UAE Cell Therapy Manufacturing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Cell Therapy Manufacturing Market Drivers
11.2 Cell Therapy Manufacturing Market Restraints
11.3 Cell Therapy Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Cell Therapy Manufacturing Industry Chain
12.2 Cell Therapy Manufacturing Upstream Analysis
12.3 Cell Therapy Manufacturing Midstream Analysis
12.4 Cell Therapy Manufacturing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Cell Therapy Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell Therapy Manufacturing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cell Therapy Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cell Therapy Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Merck KGaA Company Information, Head Office, and Major Competitors
Table 6. Merck KGaA Major Business
Table 7. Merck KGaA Cell Therapy Manufacturing Product and Solutions
Table 8. Merck KGaA Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Merck KGaA Recent Developments and Future Plans
Table 10. Avantor Company Information, Head Office, and Major Competitors
Table 11. Avantor Major Business
Table 12. Avantor Cell Therapy Manufacturing Product and Solutions
Table 13. Avantor Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Avantor Recent Developments and Future Plans
Table 15. Cell Therapies Company Information, Head Office, and Major Competitors
Table 16. Cell Therapies Major Business
Table 17. Cell Therapies Cell Therapy Manufacturing Product and Solutions
Table 18. Cell Therapies Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Cell Therapies Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Cell Therapy Manufacturing Product and Solutions
Table 23. Thermo Fisher Scientific Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 26. Charles River Laboratories Major Business
Table 27. Charles River Laboratories Cell Therapy Manufacturing Product and Solutions
Table 28. Charles River Laboratories Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Charles River Laboratories Recent Developments and Future Plans
Table 30. Catalent Company Information, Head Office, and Major Competitors
Table 31. Catalent Major Business
Table 32. Catalent Cell Therapy Manufacturing Product and Solutions
Table 33. Catalent Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Catalent Recent Developments and Future Plans
Table 35. Bio-Techne Company Information, Head Office, and Major Competitors
Table 36. Bio-Techne Major Business
Table 37. Bio-Techne Cell Therapy Manufacturing Product and Solutions
Table 38. Bio-Techne Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Bio-Techne Recent Developments and Future Plans
Table 40. Cytiva Company Information, Head Office, and Major Competitors
Table 41. Cytiva Major Business
Table 42. Cytiva Cell Therapy Manufacturing Product and Solutions
Table 43. Cytiva Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Cytiva Recent Developments and Future Plans
Table 45. Lonza Company Information, Head Office, and Major Competitors
Table 46. Lonza Major Business
Table 47. Lonza Cell Therapy Manufacturing Product and Solutions
Table 48. Lonza Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Lonza Recent Developments and Future Plans
Table 50. The Discovery Labs Company Information, Head Office, and Major Competitors
Table 51. The Discovery Labs Major Business
Table 52. The Discovery Labs Cell Therapy Manufacturing Product and Solutions
Table 53. The Discovery Labs Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. The Discovery Labs Recent Developments and Future Plans
Table 55. BIOCENTRIQ Company Information, Head Office, and Major Competitors
Table 56. BIOCENTRIQ Major Business
Table 57. BIOCENTRIQ Cell Therapy Manufacturing Product and Solutions
Table 58. BIOCENTRIQ Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BIOCENTRIQ Recent Developments and Future Plans
Table 60. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 61. FUJIFILM Diosynth Biotechnologies Major Business
Table 62. FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Product and Solutions
Table 63. FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 65. Novartis AG Company Information, Head Office, and Major Competitors
Table 66. Novartis AG Major Business
Table 67. Novartis AG Cell Therapy Manufacturing Product and Solutions
Table 68. Novartis AG Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Novartis AG Recent Developments and Future Plans
Table 70. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 71. Bristol-Myers Squibb Major Business
Table 72. Bristol-Myers Squibb Cell Therapy Manufacturing Product and Solutions
Table 73. Bristol-Myers Squibb Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Bristol-Myers Squibb Recent Developments and Future Plans
Table 75. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 76. Gilead Sciences Major Business
Table 77. Gilead Sciences Cell Therapy Manufacturing Product and Solutions
Table 78. Gilead Sciences Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Gilead Sciences Recent Developments and Future Plans
Table 80. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 81. WuXi AppTec Major Business
Table 82. WuXi AppTec Cell Therapy Manufacturing Product and Solutions
Table 83. WuXi AppTec Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. WuXi AppTec Recent Developments and Future Plans
Table 85. OXGENE Company Information, Head Office, and Major Competitors
Table 86. OXGENE Major Business
Table 87. OXGENE Cell Therapy Manufacturing Product and Solutions
Table 88. OXGENE Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. OXGENE Recent Developments and Future Plans
Table 90. Pharmaron Company Information, Head Office, and Major Competitors
Table 91. Pharmaron Major Business
Table 92. Pharmaron Cell Therapy Manufacturing Product and Solutions
Table 93. Pharmaron Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Pharmaron Recent Developments and Future Plans
Table 95. Aldevron Company Information, Head Office, and Major Competitors
Table 96. Aldevron Major Business
Table 97. Aldevron Cell Therapy Manufacturing Product and Solutions
Table 98. Aldevron Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Aldevron Recent Developments and Future Plans
Table 100. FLODESIGN SONICS Company Information, Head Office, and Major Competitors
Table 101. FLODESIGN SONICS Major Business
Table 102. FLODESIGN SONICS Cell Therapy Manufacturing Product and Solutions
Table 103. FLODESIGN SONICS Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. FLODESIGN SONICS Recent Developments and Future Plans
Table 105. Exothera Company Information, Head Office, and Major Competitors
Table 106. Exothera Major Business
Table 107. Exothera Cell Therapy Manufacturing Product and Solutions
Table 108. Exothera Cell Therapy Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Exothera Recent Developments and Future Plans
Table 110. Global Cell Therapy Manufacturing Revenue (USD Million) by Players (2018-2023)
Table 111. Global Cell Therapy Manufacturing Revenue Share by Players (2018-2023)
Table 112. Breakdown of Cell Therapy Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Cell Therapy Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Cell Therapy Manufacturing Players
Table 115. Cell Therapy Manufacturing Market: Company Product Type Footprint
Table 116. Cell Therapy Manufacturing Market: Company Product Application Footprint
Table 117. Cell Therapy Manufacturing New Market Entrants and Barriers to Market Entry
Table 118. Cell Therapy Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Cell Therapy Manufacturing Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Cell Therapy Manufacturing Consumption Value Share by Type (2018-2023)
Table 121. Global Cell Therapy Manufacturing Consumption Value Forecast by Type (2024-2029)
Table 122. Global Cell Therapy Manufacturing Consumption Value by Application (2018-2023)
Table 123. Global Cell Therapy Manufacturing Consumption Value Forecast by Application (2024-2029)
Table 124. North America Cell Therapy Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Cell Therapy Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Cell Therapy Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Cell Therapy Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Cell Therapy Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Cell Therapy Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Cell Therapy Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Cell Therapy Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Cell Therapy Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Cell Therapy Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Cell Therapy Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Cell Therapy Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Cell Therapy Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Cell Therapy Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Cell Therapy Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Cell Therapy Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Cell Therapy Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Cell Therapy Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Cell Therapy Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Cell Therapy Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Cell Therapy Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Cell Therapy Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Cell Therapy Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Cell Therapy Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Cell Therapy Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Cell Therapy Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Cell Therapy Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Cell Therapy Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Cell Therapy Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Cell Therapy Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Cell Therapy Manufacturing Raw Material
Table 155. Key Suppliers of Cell Therapy Manufacturing Raw Materials
List of Figures
Figure 1. Cell Therapy Manufacturing Picture
Figure 2. Global Cell Therapy Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell Therapy Manufacturing Consumption Value Market Share by Type in 2022
Figure 4. Autologous
Figure 5. Allogenic
Figure 6. Global Cell Therapy Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Cell Therapy Manufacturing Consumption Value Market Share by Application in 2022
Figure 8. HIV Picture
Figure 9. Autoimmune Disorders Picture
Figure 10. Immune Deficiencies Picture
Figure 11. Cancer Picture
Figure 12. Neurological Disorders Picture
Figure 13. Global Cell Therapy Manufacturing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Cell Therapy Manufacturing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Cell Therapy Manufacturing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Cell Therapy Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Cell Therapy Manufacturing Consumption Value Market Share by Region in 2022
Figure 18. North America Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Cell Therapy Manufacturing Revenue Share by Players in 2022
Figure 24. Cell Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Cell Therapy Manufacturing Market Share in 2022
Figure 26. Global Top 6 Players Cell Therapy Manufacturing Market Share in 2022
Figure 27. Global Cell Therapy Manufacturing Consumption Value Share by Type (2018-2023)
Figure 28. Global Cell Therapy Manufacturing Market Share Forecast by Type (2024-2029)
Figure 29. Global Cell Therapy Manufacturing Consumption Value Share by Application (2018-2023)
Figure 30. Global Cell Therapy Manufacturing Market Share Forecast by Application (2024-2029)
Figure 31. North America Cell Therapy Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Cell Therapy Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Cell Therapy Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Cell Therapy Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Cell Therapy Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Cell Therapy Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 41. France Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Cell Therapy Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Cell Therapy Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Cell Therapy Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 48. China Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 51. India Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Cell Therapy Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Cell Therapy Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Cell Therapy Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Cell Therapy Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Cell Therapy Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Cell Therapy Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Cell Therapy Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 65. Cell Therapy Manufacturing Market Drivers
Figure 66. Cell Therapy Manufacturing Market Restraints
Figure 67. Cell Therapy Manufacturing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Cell Therapy Manufacturing in 2022
Figure 70. Manufacturing Process Analysis of Cell Therapy Manufacturing
Figure 71. Cell Therapy Manufacturing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source